FEDERALNOE GOSUDARSTVENNOE BJUDZHETNOE UCHREZHDENIE "NAUCHNYJ TSENTR ZDOROVJA DETEJ" ROSSIJSKOJ AKADEMII MEDITSINSKIKH NAUK (FGBU "NTSZD" RAMN)
发明人:
BRIN IRINA LEONOVNA,Брин Ирина Леоновна,DUNAJKIN MIKHAIL LVOVICH,Дунайкин Михаил Львович,SHEJNKMAN OLGA GRIGOREVNA,Шейнкман Ольга Григорьевна
申请号：
RU2013132030/15
公开号：
RU0002548712C2
申请日:
2013.07.11
申请国别(地区):
RU
年份:
2015
代理人:
摘要：
FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to psychiatrics and neurology, and concerns treating epilepsy. That is ensured by administering antiepileptic preparations and immunomodulators the immunomodulators are presented by natural oral transfer factors Transfer Factor or Transfer Factor Advanced. The transfer factors are administered in age daily doses depending on the clinical encephalographic values: maximum dosages, namely: into the children under 3 years of age - 800-1,000 mg/day, 3-7 years old - 1,000-1,200 mg/ day, 7-10 years old - 1,200-1,500 mg/day, aged 10 years and older and adults - 1,500-1,800 mg/day, are indicated for the patients with the current epileptic process for 6 months after the last clinically recorded attack moderate dosages, namely: into the children under 3 years of age - 600-800 mg/day, 3-7 years old - 800-1,000 mg/ day, 7-10 years old - 1,000-1,200 mg/day, aged 10 years and older and adults - 1,200-1,500 mg/day, are used if observing clinical remission min. 1 year long the support dosages, namely: into the children under 3 years of age - 400-600 mg/day, 3-7 years old - 600-800 mg/ day, 7-10 years old - 800-1,000 mg/day, aged 10 years and older and adults - 1,000-1,200 mg/day are administered for 3 years if observing long-lasting remission, seasonal course prevention is initiated in dosages into the children under 3 years of age - 200-400 mg/day, 3-7 years old - 400-600 mg/ day, 7-10 years old - 600-800 mg/day, aged 10 years and older and adults - 800-1,000 mg/day the transfer factors in the maximum or moderate dosages are used in intercurrent diseases or psychophysical overloads.EFFECT: method provides the effective treatment of various forms of epilepsias with reducing side effects and reducing doses of the antiepileptic preparations.1 tbl, 4 exИзобретение относится к медицине, а именно к психиатрии и неврологии, и касается лечения эпилепсии. Для этого вводят противоэпилептические препараты и иммуномодуляторы, прич
